• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Here ya go! http://www.fool.com/investing/general/2015/10/16/has-eli-lilly-become-the-poster-child-f